These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 26719543)
1. IMPORTANCE OF APOPTOSIS MARKERS (MDM2, BCL-2 AND Bax) IN BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER. Saker Z; Tsintsadze O; Jiqia I; Managadze L; Chkhotua A Georgian Med News; 2015 Dec; (249):7-14. PubMed ID: 26719543 [TBL] [Abstract][Full Text] [Related]
2. Expression of p27((Kip1)), cyclin D3 and Ki67 in BPH, prostate cancer and hormone-treated prostate cancer cells. Nikoleishvili D; Pertia A; Trsintsadze O; Gogokhia N; Managadze L; Chkhotua A Int Urol Nephrol; 2008; 40(4):953-9. PubMed ID: 18317945 [TBL] [Abstract][Full Text] [Related]
3. IMPORTANCE OF APOPTOSIS MARKERS (MDM2, BCL-2 AND Bax) IN CONVENTIONAL RENAL CELL CARCINOMA. Saker Z; Tsintsadze O; Jiqia I; Managadze L; Chkhotua A Georgian Med News; 2015 Dec; (249):27-33. PubMed ID: 26719546 [TBL] [Abstract][Full Text] [Related]
4. Apoptosis-related gene expression in benign prostatic hyperplasia and prostate carcinoma. Iacopino F; Angelucci C; Lama G; Zelano G; La Torre G; D'Addessi A; Giovannini C; Bertaccini A; Macaluso MP; Martorana G; Sica G Anticancer Res; 2006; 26(3A):1849-54. PubMed ID: 16827116 [TBL] [Abstract][Full Text] [Related]
5. Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins. Tang DG; Li L; Chopra DP; Porter AT Cancer Res; 1998 Aug; 58(15):3466-79. PubMed ID: 9699682 [TBL] [Abstract][Full Text] [Related]
6. The role of FASL, BCL-2 and BAX polymorphisms in brazilian patients with prostate cancer and benign prostatic hyperplasia. da Silva Lawisch GK; Biolchi V; Kaufmann G; Nicolai G; Capitaneo E; Rosembach TR; Zang J; Brum IS; Chies JAB Mol Biol Rep; 2022 Oct; 49(10):9445-9451. PubMed ID: 35988104 [TBL] [Abstract][Full Text] [Related]
7. Reverse transcriptase-PCR analysis of apoptosis-regulating gene expression in human benign prostatic hyperplasia. Angelucci C; Iacopino F; Lama G; Zelano G; Gianesini G; Sica G; Bono AV Anticancer Res; 2005; 25(6B):3937-41. PubMed ID: 16309180 [TBL] [Abstract][Full Text] [Related]
8. Down-regulation of p27(Kip 1) cyclin-dependent kinase inhibitor in prostate cancer: distinct expression in various prostate cells associating with tumor stage and grades. Nikoleishvili D; Pertia A; Tsintsadze O; Gogokhia N; Chkhotua A Georgian Med News; 2007 Feb; (143):34-8. PubMed ID: 17404436 [TBL] [Abstract][Full Text] [Related]
9. Apoptotic and predictive factors by Bax, Caspases 3/9, Bcl-2, p53 and Ki-67 in prostate cancer after 12 Gy single-dose. Pisani C; Ramella M; Boldorini R; Loi G; Billia M; Boccafoschi F; Volpe A; Krengli M Sci Rep; 2020 Apr; 10(1):7050. PubMed ID: 32341393 [TBL] [Abstract][Full Text] [Related]
10. Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia. Shariat SF; Ashfaq R; Roehrborn CG; Slawin KM; Lotan Y J Urol; 2005 Nov; 174(5):2046-50. PubMed ID: 16217391 [TBL] [Abstract][Full Text] [Related]
11. Effect of Beclin-1 gene silencing on autophagy and apoptosis of the prostatic hyperplasia epithelial cells. Liu R; Zhang S; Wan R; Deng J; Fang W Clinics (Sao Paulo); 2022; 77():100076. PubMed ID: 36088885 [TBL] [Abstract][Full Text] [Related]
12. Ki-67 and PCNA expression in prostate cancer and benign prostatic hyperplasia. Zhong W; Peng J; He H; Wu D; Han Z; Bi X; Dai Q Clin Invest Med; 2008; 31(1):E8-E15. PubMed ID: 18312749 [TBL] [Abstract][Full Text] [Related]
13. Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor-kappaB, p53, bax, and p27 levels. Tucker CA; Kapanen AI; Chikh G; Hoffman BG; Kyle AH; Wilson IM; Masin D; Gascoyne RD; Bally M; Klasa RJ Mol Cancer Ther; 2008 Apr; 7(4):749-58. PubMed ID: 18375822 [TBL] [Abstract][Full Text] [Related]
14. Deregulation of miR-10b and miR-21 Correlate with Cancer Stem Cells Expansion through the Apoptotic Pathway in Prostate Cancer. Shukla KK; Choudhary GR; Sankanagoudar S; Misra S; Vishnoi JR; Pareek P; Pilla KK; Pandey SN; Sharma P Asian Pac J Cancer Prev; 2023 Jun; 24(6):2105-2119. PubMed ID: 37378942 [TBL] [Abstract][Full Text] [Related]
15. Abnormalities of apoptotic and cell cycle regulatory proteins in distinct histopathologic components of benign prostatic hyperplasia. Gandour-Edwards R; Mack PC; Devere-White RW; Gumerlock PH Prostate Cancer Prostatic Dis; 2004; 7(4):321-6. PubMed ID: 15314639 [TBL] [Abstract][Full Text] [Related]
16. Patterns of expression of cell cycle/apoptosis genes along the spectrum of thyroid carcinoma progression. Saltman B; Singh B; Hedvat CV; Wreesmann VB; Ghossein R Surgery; 2006 Dec; 140(6):899-905; discussion 905-6. PubMed ID: 17188136 [TBL] [Abstract][Full Text] [Related]
17. Apoptotic versus proliferative activities in human benign prostatic hyperplasia. Kyprianou N; Tu H; Jacobs SC Hum Pathol; 1996 Jul; 27(7):668-75. PubMed ID: 8698310 [TBL] [Abstract][Full Text] [Related]
18. Baicalin alleviates benign prostate hyperplasia through androgen-dependent apoptosis. Jin BR; An HJ Aging (Albany NY); 2020 Feb; 12(3):2142-2155. PubMed ID: 32018227 [TBL] [Abstract][Full Text] [Related]
19. [ Wang W; Ma F; Wang F; Yang Z; Fan S; Dou G; Gan H; Feng S; Meng Z Nan Fang Yi Ke Da Xue Xue Bao; 2022 Oct; 42(10):1503-1510. PubMed ID: 36329584 [TBL] [Abstract][Full Text] [Related]
20. Qianliening capsule treats benign prostatic hyperplasia via induction of prostatic cell apoptosis. Zheng H; Xu W; Lin J; Peng J; Hong Z Mol Med Rep; 2013 Mar; 7(3):848-54. PubMed ID: 23314795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]